Adaptyv Bio
PrivateLast Round
Seed
Sep 26, 2025
Total Funding Raised
$10.85M
Momentum Score
75 /100
Company Overview
Adaptyv Bio is a Swiss biotechnology company that is developing a next-generation protein engineering foundry. The company's platform integrates artificial intelligence, cell-free synthetic biology, robotics, and high-throughput nanofluidics to enable protein designers to rapidly design, synthesize, and test novel proteins. This technology aims to close the loop between computational design and experimental validation, accelerating the development of new medicines, industrial enzymes, and sustainable materials. Adaptyv Bio was part of the Y Combinator S21 batch and is based at the Biopole life science campus in Lausanne, Switzerland.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, ML Platforms
Business Model
B2B
Customer Profile
Usage-Based SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Adaptyv Bio Comps
Public and private peers based on sector, stage, and business model.
Adaptyv Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Sep 26, 2025 | ||||
| Debt | Jun 1, 2023 | ||||
| Pre Seed | Feb 14, 2022 | ||||
| Seed | Aug 4, 2021 | ||||
| Grant | Apr 28, 2021 |
Adaptyv Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| LongGame Ventures | Seed |
| Foundation for Technological Innovation | Debt |
| Acequia Capital | Pre Seed |
| Founders, Inc. | Pre Seed |
| ACE Ventures | Seed |
| Rheingau Founders | Pre Seed |
| byFounders | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 18, 2026
Added Cradle, a biotechnology/AI startup, as a customer.
- Apr 8, 2026
Over 50 companies now use the platform for wet lab experiments.
Adaptyv Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Adaptyv Bio's valuation, stock price, and market status.
